Life Technologies reported $103.12M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Applied Genetic Technologies AGTC:US $ 70.53M 4.84M
Ardelyx ARDX:US $ 114.22M 19.42M
Biogen BIIB:US $ 7915.9M 59.4M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Chimerix CMRX:US 62.55M 33.25M
Curis CRIS:US $ 126.14M 3.76M
Galapagos GLPG:NA 4.75B 111.15M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Life Technologies LIFE:US $ 103.12M 10.45M
Nanostring Technologies NSTG:US $ 387.13M 40.49M
Novartis NOVN:VX 37.24B 8.48B
United Therapeutics UTHR:US $ 2586.6M 263M
Xoma XOMA:US $ 89.61M 7.36M